Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T-ALL presenting with i-TLP-like indolent clinical course with repeated spontaneous regressions.
Toda Y, Ohmine K, Sano N, Nakamura N, Kihara A, Tominaga R, Noguchi A, Yokoyama D, Furuki S, Koyama S, Murahashi R, Nakashima H, Hyodo K, Kawaguchi SI, Umino K, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Fujiwara SI, Kanda Y. Toda Y, et al. Among authors: ashizawa m. Pathol Res Pract. 2024 Nov;263:155600. doi: 10.1016/j.prp.2024.155600. Epub 2024 Sep 24. Pathol Res Pract. 2024. PMID: 39326364
Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation.
Nagayama T, Fujiwara SI, Tominaga R, Yokoyama D, Noguchi A, Furuki S, Oyama T, Koyama S, Murahashi R, Nakashima H, Ikeda T, Hyodo K, Kawaguchi SI, Toda Y, Umino K, Minakata D, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kanda Y. Nagayama T, et al. Among authors: ashizawa m. Leuk Lymphoma. 2024 Sep;65(9):1350-1356. doi: 10.1080/10428194.2024.2352614. Epub 2024 May 20. Leuk Lymphoma. 2024. PMID: 38767307
Effects of CD34+ cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation.
Oyama T, Fujiwara SI, Tominaga R, Yokoyama D, Noguchi A, Furuki S, Koyama S, Murahashi R, Nakashima H, Hyodo K, Ikeda T, Kawaguchi SI, Toda Y, Nagayama T, Umino K, Minakata D, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Otsuki I, Ohmine K, Kanda Y. Oyama T, et al. Among authors: ashizawa m. Clin Transplant. 2024 Apr;38(4):e15313. doi: 10.1111/ctr.15313. Clin Transplant. 2024. PMID: 38581299
All-Perfluorosulfonated-Ionomer Composite Membranes Containing Blow-Spun Fibers: Effect of a Thin Fiber Framework on Proton Conductivity and Mechanical Properties.
Onuki S, Kawai Y, Masunaga H, Ohta N, Kikuchi R, Ashizawa M, Nabae Y, Matsumoto H. Onuki S, et al. Among authors: ashizawa m. ACS Appl Mater Interfaces. 2024 Feb 28;16(8):10682-10691. doi: 10.1021/acsami.3c17643. Epub 2024 Feb 21. ACS Appl Mater Interfaces. 2024. PMID: 38381136 Free PMC article.
Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults.
Oh I, Hatano K, Ikeda T, Toda Y, Minakata D, Kawaguchi S, Morita K, Yamamoto C, Ashizawa M, Sato K, Kameda K, Gomyo A, Misaki Y, Kawamura S, Kimura S, Kobayashi H, Sato H, Nakasone H, Ohmine K, Fujiwara S, Kako S, Kanda Y. Oh I, et al. Among authors: ashizawa m. Leuk Res. 2024 Feb;137:107438. doi: 10.1016/j.leukres.2024.107438. Epub 2024 Jan 17. Leuk Res. 2024. PMID: 38278044 Clinical Trial. No abstract available.
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma.
Yamamoto C, Minakata D, Yokoyama D, Furuki S, Noguchi A, Koyama S, Oyama T, Murahashi R, Nakashima H, Ikeda T, Kawaguchi SI, Hyodo K, Toda Y, Ito S, Nagayama T, Umino K, Morita K, Ashizawa M, Ueda M, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kanda Y. Yamamoto C, et al. Among authors: ashizawa m. Transplant Cell Ther. 2024 Jan;30(1):118.e1-118.e15. doi: 10.1016/j.jtct.2023.10.001. Epub 2023 Oct 5. Transplant Cell Ther. 2024. PMID: 37802181
Early reversal of the lymphocyte-to-monocyte ratio after allogeneic-hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis.
Nagayama T, Fujiwara SI, Tominaga R, Yokoyama D, Noguchi A, Furuki S, Oyama T, Koyama S, Murahashi R, Nakashima H, Ikeda T, Hyodo K, Kawaguchi SI, Toda Y, Umino K, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kanda Y. Nagayama T, et al. Among authors: ashizawa m. Clin Transplant. 2023 Dec;37(12):e15116. doi: 10.1111/ctr.15116. Epub 2023 Aug 29. Clin Transplant. 2023. PMID: 37641561
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.
Umino K, Morita K, Ikeda T, Kawaguchi SI, Nagayama T, Ito S, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kimura SI, Kako S, Doki N, Ozawa Y, Mori Y, Eto T, Hiramoto N, Nakamae H, Kanda J, Ichinohe T, Atsuta Y, Nakasone H, Morishima S, Kanda Y. Umino K, et al. Among authors: ashizawa m. Blood. 2023 Sep 14;142(11):1008-1021. doi: 10.1182/blood.2023019799. Blood. 2023. PMID: 37363859 Free article.
156 results